Additional file 14. Results for bulk data (CD) including DEGs, pathway enrichment analysis, drug targets results, and URs in lesional and non-lesional samples compared to healthy control.
Background: Mesothelioma is an aggressive, fatal cancer that is inextricably linked to asbestos exposure. Recent trials using a combination of the immune checkpoint inhibitors ipilimumab and nivolumab
Additional file 15: Table S3. Listing of all B. lanceolatum genes analysed in this study. Sheet 1. List of genes of B. lanceolatum analysed in this study. Red font for gene name indicates that phyloge